🧠🏃♂️ Exercise is now part of adjuvant colon cancer care. Yes, officially.
ESMO colon cancer guidelines now recommend
structured exercise programmes alongside chemotherapy in Stage II (high-risk) and Stage III colon cancer.
This is not lifestyle advice.
This is evidence-based oncology care 👇
🟣 Where does exercise fit?
🔹 Stage III colon cancer
🔹 High-risk Stage II colon cancer
🔹 During adjuvant chemotherapy + follow-up
🟣 Strength of evidence
📊 Level II evidence
📌 Grade B recommendation
📌 MCBS A score
🟣 Why this matters clinically
🧬 Improved disease-free survival
💪 Better treatment tolerance
😌 Reduced fatigue and QoL decline
📉 Lower recurrence signals
🟣 Key takeaway
Exercise is no longer optional advice.
It is part of standard adjuvant management in colon cancer.
🔖 Save this for clinics and MDTs
📖 Full guideline in comment ⬇️
#OncoTwitter#MedTwitter#ColonCancer#GIOncology@myesmo@esmo_open@asco@OncoAlert
Among women under 50, those with the highest ultraprocessed food intake had 45% higher odds of early-onset colorectal conventional adenomas versus those with the lowest intake; no significant association was seen for serrated lesions. ja.ma/4rdjS2O
The more exercise in mid- and late-life, the less Alzheimer's and all-cause dementia, adjusted for all known risk factors
jamanetwork.com/journals/jaman…
Among women under 50, those with the highest ultraprocessed food intake had 45% higher odds of early-onset colorectal conventional adenomas versus those with the lowest intake; no significant association was seen for serrated lesions. ja.ma/4r2lqxo
Viewpoint: The rise in early-onset cancers in individuals under 50 may be explained by accelerated biological aging, with aging and cancer sharing common mechanisms. ja.ma/3Hdx1Hb
#AlAire 🎙️
La Dra. Carolina Blanco (@yazbcov), médico internista y oncóloga médico del hospital ABC, habla con @LuisCardenasMx🧑💻sobre los tipos de cáncer.
102.5 FM 📻
mvsnoticias.com💻
Altas tasas de respuesta con encorafenib de primera línea más cetuximab y quimioterapia en cáncer colorrectal metastásico con mutación BRAF V600E ntk-institute.org/article/high-r… vía @docguide
Current landscape of BRAF-V600E metastatic CRC management in Latin America: an expert Latin American panel’s recommendations - ecancer ecancer.org/en/journal/art…
Invasive Disease–Free Survival Outcomes With SLNB vs Omission of Axillary Surgery in Patients With Early-Stage Breast Cancer Treated With Breast-Conserving Surgery | comment: Alexander C. J. van Akkooi MD, PhD, FRACS prac.co/l/2dppudu4 vía @practiceupdate
Efficacy and Safety of Mirvetuximab Soravtansine as a Third-Line and Later Treatment in Patients With FRα-Positive, Recurrent, Platinum-Sensitive Ovarian Cancer prac.co/l/29wd4wlt vía @practiceupdate